DNAnexus, Twist Bioscience partner on NGS data analysis

By LabPulse.com staff writers

July 13, 2022 -- DNAnexus and Twist Bioscience on Wednesday announced a collaboration aimed at reducing the time to design, validate, and commercialize next-generation sequencing (NGS)-based diagnostic tests.

As part of the collaboration, Twist customers can simplify data analysis after sequencing using the integrated DNAnexus platform with Twist's NGS Methylation Detection System and Unique Molecular Identifier (UMI) Adapter System, the firms said.

Twist's NGS Methylation Detection System provides sample preparation and target enrichment for identifying methylated regions in the human genome using highly sensitive hybridization capture-based technology that can be integrated into diagnostic tests, the firms added.

Rare diseases, cancers, and other disorders can be identified by unique methylation patterns within samples.

While the Twist UMI Adapter System detects low-frequency variants in low-input sample sources such as cell-free DNA (cfDNA) and can be used to enable cancer research, the DNAnexus platform allows users to explore and analyze complex datasets in a single, scalable, cloud-based environment.

According to the companies, the new workflow can also be used to better characterize and understand the genetic mechanisms linked to specific conditions including cancer, neurodegeneration, and rare diseases.

New RT-PCR technique augments NGS for variant classification
A relatively low-cost, high-volume RT-PCR technique used by thousands of U.S. clinical laboratories could be used for SARS-CoV-2 variant classification,...
Illumina launches research test for HRD
Illumina on Wednesday announced the launch of a next-generation sequencing (NGS)-based research-use-only test for homologous recombination deficiency...
Exact Sciences, Ultima Genomics ink supply agreement
Exact Sciences and Ultima Genomics on Tuesday announced a long-term supply agreement by which Exact will obtain access to Ultima's next-generation sequencing...
Thermo Fisher Scientific obtains CE Mark for NGS, Dx workflows
Thermo Fisher Scientific has received a CE-IVD Mark under the In Vitro Diagnostic Medical Devices Directive (IVDD) for its Ion Torrent Reporter Software...
FDA issues EUA for Labcorp NGS test to detect SARS-CoV-2 strains
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for the Laboratory Corporation of America (Labcorp) VirSeq SARS-CoV-2...

Copyright © 2022 LabPulse.com

Last Updated mp 7/13/2022 9:27:20 AM